http://english.cas.cn/newsroom/research-news/202606/t20260608_1161380.shtml
https://onlinelibrary.wiley.com/doi/10.1002/mlf2.70089
Researchers from the CAS Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) and Shenzhen Third People’s Hospital have developed a Ramanome-based phenotypic platform to improve the efficiency of bacteriophage evaluation for potential clinical use.
By combining Raman spectroscopy with a random forest model, the researchers introduced the Ramanome-based Phage Susceptibility Test (RPST). This phenotypic method reduces the turnaround time for host range verification to approximately one hour, compared to the 11–21 hours typically required by traditional plaque-based assays.
Bacteriophages offer a precise alternative to antibiotics in the fight against antimicrobial resistance. However, matching phages to clinical bacterial isolates remains challenging due to their narrow host ranges and the slow, qualitative nature of conventional assays.
The RPST framework monitors bacterial metabolic changes within 40 minutes of phage-host co-incubation and identifies four conserved Raman spectral biomarker regions linked to nucleic acids, proteins, and lipids. Combining these biomarkers into a Composite Infection Index (CII), the system achieved a 96.0% concordance rate across 25 phage-host pairs.
Unlike static assays, the continuous CII metric estimates the fraction of infected cells, enabling researchers to rank phage potency and determine the minimum MOI required to sustain infection.
While the method shows operational promise, the researchers acknowledge the need for large-scale, multi-center validation across different instruments to ensure long-term clinical reproducibility.